- Kaiser Permanente CEO & Chairman Bernard J. Tyson dies unexpectantly in his sleep today at the age of 60.
- Kaiser board of directors appoints Gregory A. Adams, Executive Vice President, and Group President, as interim Chairman and CEO.
- Bernard is survived by his wife, Denise Bradley-Tyson, and three sons; Bernard J. Tyson Jr., Alexander, and Charles.
Bernard J. Tyson, the Chairman, and CEO of Kaiser Permanente, died unexpectedly in his sleep at the age of 60, the company
Read More
Innovaccer Partners With Microsoft Teams to Launch Its Care Management Solution
Key Highlights- Innovaccer Inc. has partnered with Microsoft Teams to launch its care management product, InCare on the Microsoft Teams platform.- With Microsoft Teams, InCare can create a culture of collaboration and prevent the care teams from working in isolated silos. - Care managers can directly talk to the primary care provider’s nursing staff through the chatbot to coordinate care.Innovaccer Inc, a healthcare data activation company today announced a partnership with Microsoft Teams to
Read More
Geisinger’s KeyHIE to Deploy FHIR-Based Imaging App Across Network
Key Highlights- Geisinger’s KeyHIE has selected Life Image to become the first in the nation to implement FHIR-based imaging app to share diagnostic content in the provider portal. - From the KeyHIE provider portal, doctors can call up a patient’s medical imaging directly through the Life Image Viewer app and examine it while reading the diagnostic report within their portal.- The solution allows the integration of actionable data and clinically important information for diagnosis or treatment
Read More
Vermont Health Network Launches Pilot Project to Offer Free Genetic DNA Testing
Key Highlights
LunaPBC announces a partnership allowing patients in Vermont to donate genetic information to medical research via a partnership with the University of Vermont Health Network via Invitae.
Free genetic testing is
now offered to qualifying patients to identify increased risk for certain
diseases. Patients can then consent to securely share their data with
researchers through the LunaDNA platform.
In return, patients
receive shares of ownership in the company, allowing
Read More
Mission Bio Expands Into Single-Cell Multi-Omics With Platform That Detects DNA and Protein from the Same Cell
Key Highlights- Mission Bio expands into single-cell multi-omics with the launch of its new proprietary technology platform. - The Tapestri Platform is the first and only to enable key insights to drive the development of more impactful cancer therapies. Mission Bio, Inc., a South San Francisco, CA-based pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced its expansion into single-cell multi-omics. The company’s proprietary technology, the Tapestri
Read More
AppliedVR, NCI Partner to Evaluate VR As Therapy for Cancer-Related Anxiety
- AppliedVR announced a collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) to evaluate virtual reality (VR) as a solution to help address the underlying cancer-related anxiety. - The proof-of-concept study will evaluate AppliedVR’s virtual reality system on neuro-oncology patients’ “scanxiety,” a term used to describe the anxiety patients with cancer experience before or after medical diagnostics scans.AppliedVR, a Los Angeles, CA-based
Read More
Primary Care Doctors Use Autonomous AI to Instantly Detect Eye Disease
- A Georgia Primary Care Clinic is now using an autonomous AI system called IDx-DR to test patients for diabetic retinopathy, a leading cause of blindness.
- IDx-DR is cleared by the FDA to make an assessment without the need for a clinician to also interpret the image or results, making it usable by healthcare providers who may not normally be involved in eye care.
- The exam typically takes 5-10 minutes. Nurses use an automated fundus camera to take pictures of the patient’s retinas –
Read More
Mount Sinai’s New Precision Wellness App Compares The Effectiveness of Wellness-Related Treatment
- Mount Sinai launches new precision wellness iPhone to for individuals to compare the effectiveness of wellness-related treatments. - The app’s name is derived from what scientists call an “n-of-1” trial, in which individuals compare the effects of different treatments on themselves. - Though the N1 app will initially focus on wellness, these methods and tools may one day be more regularly used in clinical contexts.The Icahn School of Medicine at Mount Sinai, today announced the launch of a new
Read More
Philips Launches Next-Gen Vital Signs Monitor for Early Patient Intervention
- Philips debuts EarlyVue VS30 vital signs monitor and receive 510(k) clearance in the U.S.- Early Warning Scoring, predictive trend analytics and intelligent algorithms help detect patient deterioration earlier to enable timely intervention.Royal Philips today announced the debut of EarlyVue VS30, a new vital signs monitor, in the U.S. Expanding on Philips’ General Care solutions portfolio, Philips EarlyVue VS30 uses automated Early Warning Scoring (EWS) to collect critical vital signs and
Read More
Boston U Launches First-Ever Virtual Alzheimer’s Disease Population Health Study
- Savonix and Boston University School of Public Health launches the first-ever population health Alzheimer’s Disease Discovery Study (ASSIST) to digitally collect brain health data from over 400k participants.- First-ever wholly digital population health study that captures data from multiple wearable technologies together with sensitive neuropsychology tests to examine how risks for dementia cluster to produce diseases like Alzheimer’s.- Study data will power first time knowledge of how
Read More
